Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Open Forum Infectious Diseases|December 16, 2020
Diabetes Modifies the Clinic Presentation of Cutaneous LeishmaniasisAlexsandro S Lago, Filipe R Lima, Augusto M Carvalho, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2007
Cutaneous leishmaniasis during pregnancy: exuberant lesions and potential fetal complicationsDaniel J Morgan, Luiz H Guimaraes, Paulo R L Machado, et al.
BMC Infectious Diseases|April 28, 2006
Differential effects of antigens from L. braziliensis isolates from disseminated and cutaneous leishmaniasis on in vitro cytokine productionPaulo T G Leopoldo, Paulo R L Machado, Roque P Almeida, et al.
Pathogens (Basel, Switzerland)|May 24, 2024
Improved Treatment Outcome Following the Use of a Wound Dressings in Cutaneous Leishmaniasis LesionsPedro B Borba, Jamile Lago, Tainã Lago, et al.
Emerging Infectious Diseases|June 16, 2009
Geographic clustering of leishmaniasis in northeastern BrazilAlbert Schriefer, Luiz H Guimarães, Paulo R L Machado, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2016
Fluconazole in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis: A Randomized Controlled TrialFernanda V de O Prates, Mayra E F Dourado, Silvana C Silva, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2020
A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in BrazilPaulo R L Machado, Fernanda V O Prates, Viviane Boaventura, et al.
Infection and Immunity|November 22, 2005
Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasisDaniela R Faria, Kenneth J Gollob, José Barbosa, et al.
Tropical Medicine & International Health : TM & IH|June 21, 2018
Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trialPaulo R L Machado, Camila S Ribeiro, Jaqueline França-Costa, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 15, 2024
Use of topical rSm29 in combination with intravenous meglumine antimoniate in the treatment of cutaneous leishmaniasis: A randomized controlled trialTainã Lago, Fábio Peixoto, Fábio Mambelli, et al.
Pageof 5